Evidence map›Paper›PMID 40735717›Full record

ArticleClinical case reports2025

Spurious Hyperphosphatemia From Alteplase-Treated Catheter: A Case Report and Literature Review.

Ahmad Matarneh, Sundus Sardar, Omar Salameh, Muhammad Abdulbasit, Wardah Iqbal, Monika Koirala, Taryn Millete, Ronald Miller, Nasrollah Ghahramani, Navin Verma

Erratum issuedAbstract read
In one paragraph

Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Ahmad MatarnehDepartment of Nephrology Pennsylvania State Milton S. Hershey Medical Center Hershey Pennsylvania USA.ORCID https://orcid.org/0000-0002-7091-310X
Sundus SardarDepartment of Nephrology Pennsylvania State Milton S. Hershey Medical Center Hershey Pennsylvania USA.ORCID https://orcid.org/0000-0002-1727-0520
Omar SalamehUniversity Health Truman Medical Center Kansas City Missouri USA.ORCID https://orcid.org/0000-0002-9190-0439
Muhammad AbdulbasitDepartment of Nephrology Pennsylvania State Milton S. Hershey Medical Center Hershey Pennsylvania USA.
Wardah IqbalAkthar Saeed Medical and Dental College Lahore Pakistan.
Monika KoiralaInternal Medicine Residency Program UPMC-Lititz Lititz Pennsylvania USA.
Taryn MilletePennsylvania State Milton S. Hershey Medical Center Hershey Pennsylvania USA.
Ronald MillerDepartment of Nephrology Pennsylvania State Milton S. Hershey Medical Center Hershey Pennsylvania USA.
Nasrollah GhahramaniDepartment of Nephrology Pennsylvania State Milton S. Hershey Medical Center Hershey Pennsylvania USA.
Navin VermaDepartment of Nephrology Pennsylvania State Milton S. Hershey Medical Center Hershey Pennsylvania USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Falsely elevated phosphate levels can occur when blood is drawn after alteplase use in dialysis catheters due to phosphorus-containing excipients. Recognizing spurious hyperphosphatemia is important to prevent misdiagnosis, avoid inappropriate treatment changes, and ensure accurate phosphate monitoring in patients undergoing maintenance hemodialysis.

Indexed as

electrolyte imbalanceend‐stage renal diseasehyperphosphatemiarenal dialysistissue plasminogen activatorvascular access devices

Identifiers

PMID40735717
PMCPMC12301157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.